PRESS RELEASE published on 06/19/2023 at 17:57, 2 years 5 months ago EVN AG: Changes on the Supervisory Board and Executive Board of EVN AG
PRESS RELEASE published on 06/19/2023 at 16:35, 2 years 5 months ago EQS-Adhoc: EVN AG: Early termination of appointment of the member of the executive board Franz Mittermayer; invitation to apply for nomination will be issued
PRESS RELEASE published on 05/25/2023 at 07:30, 2 years 6 months ago EVN AG: Business development in the first half of 2022/23
PRESS RELEASE published on 05/15/2023 at 18:52, 2 years 6 months ago EQS-Adhoc: EVN AG: The management board proposes the distribution of a special dividend for the 2022/23 financial year and specifies expected Group net result for 2022/23
PRESS RELEASE published on 04/11/2023 at 18:32, 2 years 7 months ago EQS-Adhoc: EVN AG: Chairwoman of the supervisory board resigns
PRESS RELEASE published on 02/21/2023 at 07:30, 2 years 9 months ago EVN AG: Business development in the first quarter of 2022/23
Published on 12/05/2025 at 02:35, 3 hours 50 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 5 hours 25 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 7 hours 20 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 7 hours 25 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 03:30, 2 hours 54 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 6 hours 34 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 9 hours 59 minutes ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 10 hours 10 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 19:10, 11 hours 14 minutes ago SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance
Published on 12/04/2025 at 18:00, 12 hours 25 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 12 hours 40 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 12 hours 41 minutes ago Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 23 hours 24 minutes ago bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 12 hours ago Declaration of voting rights at the end of November 2025
